HTLV-I and HTLV-II peptide antigens and methods

Details HTLV-I and HTLV-II peptide antigens and methods HTLV-I and HTLV-II peptide antigens and methods

1995-06-07

1998-09-29

Smith, Lynette F.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

530350, 435 71, 435 72, 435974, 435975, C12Q 170, G01N 2353, G01N 33567, G01N 33564

Patent

active

058144412

ABSTRACT:
Novel HTLV-I and HTLV-II peptide antigens are disclosed for use in diagnostics assays for screening and confirming HTLV-I and HTLV-II antisera. The peptides are derived from analogous regions of HTLV-I and HTLV-II gp46 envelope proteins, and are differentiated by their immunoreactivity with an HTLV-II specific monoclonal antibody and by HTLV-I and HTLV-II antisera. The peptides are also useful in vaccine compositions.

REFERENCES:
patent: 4588681 (1986-05-01), Sawada et al.
patent: 4645738 (1987-02-01), Knowles et al.
patent: 4661445 (1987-04-01), Saxinger et al.
patent: 4663436 (1987-05-01), Elder et al.
patent: 4689398 (1987-08-01), Wu et al.
patent: 4722888 (1988-02-01), Broder et al.
patent: 4724258 (1988-02-01), Yoshida et al.
patent: 4735896 (1988-04-01), Wang et al.
patent: 4743678 (1988-05-01), Essex et al.
patent: 4757000 (1988-07-01), Tohmatsu et al.
patent: 5003043 (1991-03-01), Akita et al.
patent: 5017687 (1991-05-01), Vahlne et al.
patent: 5039604 (1991-08-01), Papsidero
patent: 5066579 (1991-11-01), Reyes
Anderson, D.W. et al., MMWR 37,48:737-747 (1988).
Anderson, D.W. et al., Blood 74,7:2585-2591 (1989).
Blattner, W.A. et al., Int. J. Cancer 30:257-264 (1982).
Blattner, W.A. et al., JAMA 250,8:1074-1080 (1983).
Blayney, D.W. et al., JAMA 250,8:1048-1052 (1983).
Catovsky, D. et al., Lancet, 1,8273:639-643 (1982).
Chen, Y-M. A. et al., J. Virology 63,11:4952-4957 (1989).
Chen, Y-M. A. et al., Lancet 33:1153-1155 (1990).
Cianciolo, G.J. et al., Science 230:453-455 (1985).
Clapham, P. et al., Proc Natl. Acad. Sci. USA 81:2886-2889 (1984).
Essex, M. et al., Science 221:1061-1064 (1983).
Gallo, R.C. et al., Proc. Natl. Acad. Sci. USA 79:5680-5683 (1982).
Gallo, R.C. et al., Cancer Res. 43:3892-3899 (1983).
Halbert, S.P. et al., J. Clin. Microbiol. 23,2:212-216 (1986).
Hattori, S. et al., Virology 136:338-347 (1984).
Horal, P. et al., Proc. Natl. Acad. Sci. USA 88:5754-5788 (Jul. 1991).
Itamura, S. et al., Gene 38:57-64 (1985).
Iwatsuki, K. et al., Jpn. J. Dermatol. 99:1059-1065 (1989).
Kiyokawa, T. et al., Proc. Natl. Acad. Sci. USA 81:6202-6206 (1984).
Kline, R.L. et al., Lancet 337:30-33 (1991).
Lal, R.B. et al., J. Infect. Dis. 163:41-46 (1991).
Lal, R.B. et al., J. Clin. Microbiol. 29,10:2253-2258 (1991).
Lee, T.H. et al., Proc. Natl. Acad. Sci. USA 81:3856-3860 (1984).
Lillehoj, E.P. et al., J. Clin. Microbiol. 28,12:2653-2658 (1990).
Matsushita, S. et al., Proc. Natl. Acad. Sci. USA 83:2672-2676 (1986).
Newman, M.J. et al., Virology 150:106-116 (1986).
Nyunoya, H. et al., AIDS Res. H. Retroviruses 6,11:1311-1321 (1990).
Oroszlan, S. and Copeland, T.D., Current Topics in Microbiol. and Immunol. 115:221-233 (1985).
Palker, T.J. et al., J. Immunol. 142:971-978 (1989).
Patarca, R. and Haseltine, W. A., Nature 309:728 (1984).
Poiesz, B.J. et al., Proc. Natl. Acad. Sci. USA 77:7415-7419 (1980).
Poiesz, B.J. et al., Nature 294:268-271 (1981).
Ralph, R.K., Nature 311:515 (1984).
Ralston, S. et al., J. Biol. Chem. 264,28:16343-16346 (1989).
Robert-Guroff, M. et al., J. Exper. Med. 154:1957-1964 (1981).
Robert-Guroff, M. et al., J. Exper. Med. 157:248-258 (1983).
Robert-Guroff, M. and Shepard, E., J. Virology 53,1:214-220 (1985).
Samuel, K.P. et al., Science 226:1094-1097 (1984).
Saxinger, W. et al., Science (Sep. 28) 225:1473-1476 (1984).
Schupbach, J. et al., Science 224:607-610 (1984).
Seiki, M. et al., Proc. Natl. Acad. Sci. USA 80:3618-3622 (1983).
Shimoyama, M. et al., Jpn. J. Clin. Oncol. 12,1:109-116 (1982).
Slamon, D.J. et al., Science 226:61-65 (1984).
Sodroski, J. et al., Science 225:421-424 (1984).
Sugamura, K. et al., J. Immun. 132,6:3180-3184 (1984).
Tanaka, Y. et al., Int. J. Cancer 36:549-555 (1985).
Tanaka, Y. et al., Int. J. Cancer 46:675-681 (1990).
Viscidi, R.P. et al., J. AIDS 4:1190-1198 (1991).
Wang, J. J. G. et al., Proc. Natl. Acad. Sci. USA 83:6159-6163 (1986).
Washitani et al., Int. J. Cancer 49:173-177 (1991).
Wiktor S.Z. et al., Lancet 335:1533 (1990).
Wiktor S.Z. et al., Lancet 338:512-513 (1991).
Williams, A. E. et al., Science 240:643-646 (1988).
Williams, A. E. et al., MMWR 39,50:915-924 (1990).
Yoshida, M. et al., Proc. Natl. Acad. Sci. USA 79:2031-2035 (1982).

Affiliated with

Also associated with

Rating

HTLV-I and HTLV-II peptide antigens and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HTLV-I and HTLV-II peptide antigens and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HTLV-I and HTLV-II peptide antigens and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-685107